IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to ...
Revenue of $290.3 million in Q3, up 2.7% versus prior yearDiluted EPS of $1.22 in Q3 increased approximately 15% versus prior yearReduced leverage to 2.5x in Q3, driven by strong profitability and cas ...